Oligosol Zinc Nickel Cobalt Ampoules – 28 x 2ml Support for Weight Loss Diets

For Whom:

• Adults and Adolescents (15+)
• Not suitable for: Pregnant or breastfeeding women

Product Description:
Oligosol Zinc Nickel Cobalt Ampoules are designed for use in oligotherapy to support individuals as a terrain modifier during weight loss diets. This unique formulation combines essential trace elements to help optimize the body's natural balance during slimming efforts.

Key Benefits:

• Complements weight loss programs by addressing terrain imbalances.
• Easy-to-use sublingual ampoules for enhanced absorption.

Active Ingredients:
Each ampoule contains:

• Zinc Gluconate
• Nickel Gluconate
• Cobalt Gluconate
• Excipients: Anhydrous glucose, purified water.

How to Use:

• Dosage: 2 to 3 ampoules daily.
• Administer sublingually (under the tongue) for 1–2 minutes before swallowing.
• Best taken:
  • In the morning on an empty stomach.
  • 15 minutes before meals.
  • Or at bedtime.

Packaging:

• 28 ampoules (2ml each) per box, with a self-breaking design for convenience.

Precautions for Use:

• Not suitable for individuals with glucose-galactose malabsorption syndrome.
• Do not use if allergic to any of the listed ingredients.
• Pregnancy and breastfeeding: Use is not recommended.

Why Choose Oligosol Zinc Nickel Cobalt?
This specialized formula provides trace elements that work synergistically to support the body during weight loss diets. Developed with a focus on balance and well-being, these ampoules are ideal for adults and adolescents seeking a holistic approach to their slimming journey.

Please read the following full disclosure before purchasing or using this product.

SUMMARY OF PRODUCT CHARACTERISTICS
ANSM - Updated on: 01/08/2023

1. NAME OF THE MEDICINAL PRODUCT

ZINC-NICKEL-COBALT OLIGOSOL, oral solution in ampoules

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

• Zinc Gluconate: 0.470 mg
  • (Equivalent to zinc: 0.0674 mg)
• Nickel Gluconate: 0.555 mg
  • (Equivalent to nickel: 0.0726 mg)
• Cobalt Gluconate: 0.553 mg
  • (Equivalent to cobalt: 0.0726 mg)

Per 2 ml ampoule.

Excipient with known effect: Glucose.

For the full list of excipients, see section 6.1.

3. PHARMACEUTICAL FORM

Oral solution in ampoules.

4. CLINICAL DATA

4.1. Therapeutic Indications

Used as a terrain modifier, particularly in the context of a weight-loss diet.

4.2. Dosage and Method of Administration

Dosage

• FOR ADULTS ONLY.
• 2 to 3 ampoules per day.

Administration Schedule

• Preferably in the morning on an empty stomach.
• Alternatively, 15 minutes before meals or at bedtime.

Method of Administration

• Oral use.
• Sublingual administration is recommended: hold the contents of the ampoule under the tongue for 1 to 2 minutes before swallowing.

4.3. Contraindications

• Hypersensitivity to the active substances or any of the excipients listed in section 6.1.

4.4. Special Warnings and Precautions for Use

• Treatment with these trace mineral elements does not replace any specific treatments that may be required.
• This medication contains glucose. Its use is not recommended in patients with glucose-galactose malabsorption syndrome.

4.5. Interactions with Other Medicinal Products and Other Forms of Interaction

• Available data do not suggest the existence of clinically significant interactions.

4.6. Fertility, Pregnancy, and Lactation

• In the absence of experimental or clinical data, and as a precaution, the use of this medication should be avoided during pregnancy and breastfeeding.

4.7. Effects on the Ability to Drive and Use Machines

• Not applicable.

4.8. Undesirable Effects

• Skin and subcutaneous tissue disorders have been reported but do not confirm true allergies. The frequency is indeterminable.

Reporting Suspected Adverse Reactions

• Reporting suspected adverse reactions after authorization is important for ongoing monitoring of the benefit-risk balance of the medication. Health professionals should report any suspected adverse reactions through the national reporting system: ANSM (National Agency for the Safety of Medicines and Health Products) via www.signalement-sante.gouv.fr.

4.9. Overdose

• No cases of overdose have been reported.

5. PHARMACOLOGICAL PROPERTIES

5.1. Pharmacodynamic Properties

• Pharmacotherapeutic class: OLIGOTHERAPY (V: Various)
• Trace mineral element.

5.2. Pharmacokinetic Properties

• Not available.

5.3. Preclinical Safety Data

• Not available.

6. PHARMACEUTICAL DATA

6.1. List of Excipients

• Anhydrous glucose, purified water.

6.2. Incompatibilities

• Not applicable.

6.3. Shelf Life

• 5 years.

6.4. Special Storage Precautions

• Store at a temperature below 25°C.

6.5. Nature and Contents of Container

• 2 ml clear glass ampoules with self-breaking tips.
• Pack sizes: 14 or 28 ampoules.

6.6. Special Precautions for Disposal and Handling

• No special requirements.

7. MARKETING AUTHORIZATION HOLDER

LABCATAL
1198 Avenue du Docteur Maurice Donat
ZAC du Font de l’Orme
06250 Mougins, France

8. MARKETING AUTHORIZATION NUMBER(S)

• 34009 307 526 3 0: 2 ml ampoules (clear glass), box of 14.
• 34009 375 478 0 2: 2 ml ampoules (clear glass), box of 28.

9. DATE OF FIRST AUTHORIZATION/RENEWAL OF AUTHORIZATION

• [To be completed later by the marketing authorization holder]

10. DATE OF TEXT REVISION

• [To be completed later by the marketing authorization holder]

11. DOSIMETRY

• Not applicable.

12. INSTRUCTIONS FOR PREPARATION OF RADIOPHARMACEUTICALS

• Not applicable.

CONDITIONS OF PRESCRIPTION AND SUPPLY

• Medicine not subject to medical prescription.